Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109739095> ?p ?o ?g. }
- W3109739095 endingPage "320" @default.
- W3109739095 startingPage "312" @default.
- W3109739095 abstract "Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or intolerance to at least one biologic disease-modifying antirheumatic drug (DMARD). Methods In this 24-week randomised, placebo-controlled, double-blind, phase 3 trial, 642 patients were randomised (2:2:1:1) to once per day upadacitinib 15 mg or 30 mg, placebo followed by upadacitinib 15 mg or placebo followed by upadacitinib 30 mg at week 24. The primary endpoint was the proportion of patients achieving American College of Rheumatology (ACR) 20 response at week 12. Achievement of minimal disease activity (MDA) was assessed at week 24. Treatment-emergent adverse events are reported for all patients who received at least one dose of trial drug. Results At week 12, significantly more patients receiving upadacitinib 15 mg and 30 mg versus placebo achieved ACR20 (56.9% and 63.8% vs 24.1%; p<0.001 for both comparisons). At week 24, MDA was achieved by more upadacitinib 15 mg-treated (25.1%) and 30 mg-treated patients (28.9%) versus placebo (2.8%; p<0.001 for both comparisons). Generally, the rates of treatment-emergent adverse events were similar with placebo and upadacitinib 15 mg and higher with upadacitinib 30 mg at week 24. Rates of serious infections were 0.5%, 0.5% and 2.8% with placebo, upadacitinib 15 mg and upadacitinib 30 mg, respectively. Conclusion In this trial of patients with active PsA who had inadequate response or intolerance to at least one biologic DMARD, upadacitinib 15 mg and 30 mg was more effective than placebo over 24 weeks in improving signs and symptoms of PsA. Clinical trial registration number NCT03104374" @default.
- W3109739095 created "2020-12-07" @default.
- W3109739095 creator A5006822602 @default.
- W3109739095 creator A5008286260 @default.
- W3109739095 creator A5010280825 @default.
- W3109739095 creator A5012348347 @default.
- W3109739095 creator A5017320787 @default.
- W3109739095 creator A5032707830 @default.
- W3109739095 creator A5033983216 @default.
- W3109739095 creator A5034557315 @default.
- W3109739095 creator A5038508576 @default.
- W3109739095 creator A5052170557 @default.
- W3109739095 creator A5062649381 @default.
- W3109739095 creator A5070478316 @default.
- W3109739095 creator A5081778211 @default.
- W3109739095 creator A5086788519 @default.
- W3109739095 date "2020-12-03" @default.
- W3109739095 modified "2023-10-16" @default.
- W3109739095 title "Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2" @default.
- W3109739095 cites W1935617463 @default.
- W3109739095 cites W2017932566 @default.
- W3109739095 cites W2054242247 @default.
- W3109739095 cites W2067327580 @default.
- W3109739095 cites W2083180635 @default.
- W3109739095 cites W2108984264 @default.
- W3109739095 cites W2113717019 @default.
- W3109739095 cites W2119067278 @default.
- W3109739095 cites W2161369617 @default.
- W3109739095 cites W2223868808 @default.
- W3109739095 cites W2512436288 @default.
- W3109739095 cites W2584591968 @default.
- W3109739095 cites W2620369605 @default.
- W3109739095 cites W2766717228 @default.
- W3109739095 cites W2766846920 @default.
- W3109739095 cites W2789710874 @default.
- W3109739095 cites W2805265384 @default.
- W3109739095 cites W2807791746 @default.
- W3109739095 cites W2808333862 @default.
- W3109739095 cites W2884090647 @default.
- W3109739095 cites W2896175664 @default.
- W3109739095 cites W2946233321 @default.
- W3109739095 cites W2961111920 @default.
- W3109739095 cites W3027539208 @default.
- W3109739095 cites W3041856700 @default.
- W3109739095 cites W3159598855 @default.
- W3109739095 doi "https://doi.org/10.1136/annrheumdis-2020-218870" @default.
- W3109739095 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7892371" @default.
- W3109739095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33272960" @default.
- W3109739095 hasPublicationYear "2020" @default.
- W3109739095 type Work @default.
- W3109739095 sameAs 3109739095 @default.
- W3109739095 citedByCount "107" @default.
- W3109739095 countsByYear W31097390952020 @default.
- W3109739095 countsByYear W31097390952021 @default.
- W3109739095 countsByYear W31097390952022 @default.
- W3109739095 countsByYear W31097390952023 @default.
- W3109739095 crossrefType "journal-article" @default.
- W3109739095 hasAuthorship W3109739095A5006822602 @default.
- W3109739095 hasAuthorship W3109739095A5008286260 @default.
- W3109739095 hasAuthorship W3109739095A5010280825 @default.
- W3109739095 hasAuthorship W3109739095A5012348347 @default.
- W3109739095 hasAuthorship W3109739095A5017320787 @default.
- W3109739095 hasAuthorship W3109739095A5032707830 @default.
- W3109739095 hasAuthorship W3109739095A5033983216 @default.
- W3109739095 hasAuthorship W3109739095A5034557315 @default.
- W3109739095 hasAuthorship W3109739095A5038508576 @default.
- W3109739095 hasAuthorship W3109739095A5052170557 @default.
- W3109739095 hasAuthorship W3109739095A5062649381 @default.
- W3109739095 hasAuthorship W3109739095A5070478316 @default.
- W3109739095 hasAuthorship W3109739095A5081778211 @default.
- W3109739095 hasAuthorship W3109739095A5086788519 @default.
- W3109739095 hasBestOaLocation W31097390951 @default.
- W3109739095 hasConcept C126322002 @default.
- W3109739095 hasConcept C126894567 @default.
- W3109739095 hasConcept C142724271 @default.
- W3109739095 hasConcept C197934379 @default.
- W3109739095 hasConcept C198451711 @default.
- W3109739095 hasConcept C203092338 @default.
- W3109739095 hasConcept C204787440 @default.
- W3109739095 hasConcept C27081682 @default.
- W3109739095 hasConcept C2776260265 @default.
- W3109739095 hasConcept C2777077863 @default.
- W3109739095 hasConcept C535046627 @default.
- W3109739095 hasConcept C71924100 @default.
- W3109739095 hasConcept C90924648 @default.
- W3109739095 hasConcept C98274493 @default.
- W3109739095 hasConceptScore W3109739095C126322002 @default.
- W3109739095 hasConceptScore W3109739095C126894567 @default.
- W3109739095 hasConceptScore W3109739095C142724271 @default.
- W3109739095 hasConceptScore W3109739095C197934379 @default.
- W3109739095 hasConceptScore W3109739095C198451711 @default.
- W3109739095 hasConceptScore W3109739095C203092338 @default.
- W3109739095 hasConceptScore W3109739095C204787440 @default.
- W3109739095 hasConceptScore W3109739095C27081682 @default.
- W3109739095 hasConceptScore W3109739095C2776260265 @default.
- W3109739095 hasConceptScore W3109739095C2777077863 @default.
- W3109739095 hasConceptScore W3109739095C535046627 @default.
- W3109739095 hasConceptScore W3109739095C71924100 @default.